Publication | Closed Access

Baicalin alleviates atherosclerosis by relieving oxidative stress and inflammatory responses via inactivating the NF-κB and p38 MAPK signaling pathways

InflammationInflammatory ResponsesAnti-inflammatoryCell SignalingMedicinePhysiologyImmunologyChronic InflammationVascular BiologyMetabolic SignalingPharmacologyInflammatory DiseaseAtherosclerosisOxidative Stress